Form 4 for PLRX PLIANT THERAPEUTICS, INC.
Accepted 2022-12-27 00:00:00 ET · period of report 2022-12-22 · accession 0001140361-22-047041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-27 | 2022-12-22 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +4,000 | 84.4K | +5% | +$8,320 |
| D | 2022-12-27 | 2022-12-22 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $0.00 | -4,000 | 146.1K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-22 | M | A | 4,000 | $2.08 | 84,424 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-12-22 | M | D | 4,000 | $0.00 | 146,097 | D | $2.08 · — to 2029-01-23 | 4,000 Common Stock | (F1) 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |